Skip to main navigation Skip to search Skip to main content

STOPP criteria and Beers' criteria for potentially inappropriate medications (PIMs), and START criteria for potential prescribing omissions (PPOs)

Research output: Chapter in Book/Report/Conference proceedingsChapterpeer-review

Abstract

Potentially inappropriate medications or “PIMs” are highly prevalent in older people with multimorbid illness and associated polypharmacy. Polypharmacy is the principal risk factor for PIMs, and there is a known causal link connecting polypharmacy with adverse drug reactions (ADRs) and adverse drug events (ADEs) which are for the most part mediated by PIMs. For this reason, it is considered clinically important to detect PIMs during routine medication review. Potential prescribing omissions or “PPOs” are also clinically important to detect and assess as PPOs are also associated with adverse clinical outcomes in multimorbid older people. A careful balance between PIM and PPO avoidance is an important consideration in medication optimization in multimorbid older people experiencing polypharmacy.

Original languageEnglish
Title of host publicationMedications for Older Persons
Subtitle of host publicationRecommendations, Harms, Evidence
PublisherElsevier
Pages1-16
Number of pages16
ISBN (Electronic)9780443290251
ISBN (Print)9780443290268
DOIs
Publication statusPublished - 25 Nov 2025

Keywords

  • Inappropriate prescribing
  • Multimorbidity
  • Older people
  • Polypharmacy
  • Potential prescribing omissions (PPOs)
  • Potentially inappropriate medications (PIMs)

Fingerprint

Dive into the research topics of 'STOPP criteria and Beers' criteria for potentially inappropriate medications (PIMs), and START criteria for potential prescribing omissions (PPOs)'. Together they form a unique fingerprint.

Cite this